1. Home
  2. CAPT vs BNGO Comparison

CAPT vs BNGO Comparison

Compare CAPT & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAPT

Captivision Inc.

HOLD

Current Price

$0.06

Market Cap

13.7M

Sector

Finance

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.17

Market Cap

12.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAPT
BNGO
Founded
2005
2003
Country
South Korea
United States
Employees
98
97
Industry
Blank Checks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
12.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CAPT
BNGO
Price
$0.06
$1.17
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
58.6M
142.4K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.50
EPS
N/A
N/A
Revenue
N/A
$12,000,735.00
Revenue This Year
N/A
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$0.05
$1.06
52 Week High
$1.93
$5.50

Technical Indicators

Market Signals
Indicator
CAPT
BNGO
Relative Strength Index (RSI) 24.24 43.82
Support Level N/A $1.09
Resistance Level $0.61 $1.18
Average True Range (ATR) 0.07 0.07
MACD -0.03 -0.01
Stochastic Oscillator 3.27 14.29

Price Performance

Historical Comparison
CAPT
BNGO

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: